![Bing Yuan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bing Yuan active positions
Companies | Position | Start | End |
---|---|---|---|
OnCusp Therapeutics6
![]() OnCusp Therapeutics6 Miscellaneous Commercial ServicesCommercial Services OnCusp Therapeutics is a biotechnology company based in New York, NY and has subsidiaries in China. OnCusp Therapeutics specializes in developing preclinical assets to clinical proof of concept and then partnering out for commercialization in the field of oncology therapeutics. The company is committed to accelerating the advancement of oncology assets by leveraging its deep translational and clinical development expertise. OnCusp Therapeutics is backed by prominent investors including Sequoia Capital, Biotrack Capital, Oriza Seed Capital, and AIHC Capital. The company was founded in 2021 by Andy Fu, Bing Yuan, and Eric Slosberg, with Bing Yuan serving as the CEO since then. | Chief Executive Officer | - | - |
Chairman | - | - | |
Founder | - | - | |
Shanghai OnCusp Pharmaceutical Co. Ltd. | Director/Board Member | - | - |
Career history of Bing Yuan
Statistics
International
Cayman Islands | 2 |
China | 2 |
Operational
Chief Executive Officer | 1 |
Chairman | 1 |
Founder | 1 |
Sectoral
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
OnCusp Therapeutics6
![]() OnCusp Therapeutics6 Miscellaneous Commercial ServicesCommercial Services OnCusp Therapeutics is a biotechnology company based in New York, NY and has subsidiaries in China. OnCusp Therapeutics specializes in developing preclinical assets to clinical proof of concept and then partnering out for commercialization in the field of oncology therapeutics. The company is committed to accelerating the advancement of oncology assets by leveraging its deep translational and clinical development expertise. OnCusp Therapeutics is backed by prominent investors including Sequoia Capital, Biotrack Capital, Oriza Seed Capital, and AIHC Capital. The company was founded in 2021 by Andy Fu, Bing Yuan, and Eric Slosberg, with Bing Yuan serving as the CEO since then. | Commercial Services |
Shanghai OnCusp Pharmaceutical Co. Ltd. |
- Stock Market
- Insiders
- Bing Yuan
- Experience